课题基金 / 基金详情

Potential usage of endothelial progenitor cells (EPC) in neovascularization

Potential usage of endothelial progenitor cells (EPC) in neovascularization
内皮祖细胞 (EPC) 在新生血管形成中的潜在用途
批准号:
15500313
负责人:
YOSHIDA Masayuki
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

YOSHIDA Masayuki的其他基金

相似基金

相关文献

中文摘要
翻译
在这个项目中,我们研究了内皮祖细胞(EPC)在新生血管中的潜在用途,特别是支持其粘附到成熟血管内皮的分子机制。在项目的第一年,我们能够在体外建立EPC培养体系。此外,我们还使用EPC进行了生理流动条件下的粘附实验。我们发现,与未激活的内皮相比,激活血管内皮的细胞因子显著上调EPC的粘附。当我们用抗e -选择素、ICAM 1和VCAM-1的粘附阻断抗体预处理这些血管内皮时,抗e -选择素抗体而非其他抗体阻断了EPC与内皮的粘附,提示e -选择素在EPC粘附中起重要作用。第二年,我们建立了裸鼠后肢缺血新生血管模型。如前所述,向这些小鼠注射EPC可显著改善其后肢新生血管的形成。当EPC数量减少到最佳数量的五分之一时,血流恢复明显减弱。然而,当引入含有e -选择素cDNA的腺病毒表达e -选择素时,新生血管明显恢复。这些数据提示e -选择素在新生血管中的潜在功效。
英文摘要
In this project, we investigated potential usage of endothelial progenitor cells (EPC) in neovascularization especially molecular mechanisms that support their adhesion to mature vascular endothelium. In the first year of the project, we were able to establish culture system of EPC in vitro. Moreover, we conducted an adhesion assay under physiological flow condition using EPC. We found that cytokine activation of vascular endothelium significantly upregulated adhesion of EPC when compared to unactivated endothelium. When we pretreated these vascular endothelium with adhesion blocking antibodies against E-selectin, ICAM 1, and VCAM-1, anti-E-selectin antibody but not other antibodies blocked adhesion of EPC to endothelium, suggesting an important role for E-selectin in EPC adhesion. In the second year, we developed a neovascularization model using ischemic hindlimb in nude mice. Injection of EPC to these mice significantly improved their neovascularization in the hindlimb as previously reported. When amount of EPC was reduced to one-fifth of the optimal number, the recovery of blood flow was significantly attenuated. However, when adenovirus containing E-selectin cDNA was introduced to express E-selectin, neovascularization was significantly restored. These data suggested that potential efficacy of E-selectin in neovascularization.
期刊论文(66)
专著(0)
科研奖励(0)
会议论文
Fluvastatin inhibits recruitment of HIV envelope protein-triggered CD+4 I cell to vascular endothelium
氟伐他汀抑制 HIV 包膜蛋白触发的 CD 4 I 细胞向血管内皮的募集
DOI: --
发表时间: 2004
期刊: Circulation J.Suppl. 68
影响因子: --
作者: [Y.Takano, K.Shimokado, Y.Hata, M.Yoshida]
通讯作者: M.Yoshida
DOI: 10.1016/j.lfs.2004.02.028
发表时间: 2004-07-30
期刊: LIFE SCIENCES
影响因子: 6.1
作者: [Hiraoka, M, Nitta, N, Yoshida, M]
通讯作者: Yoshida, M
DOI: 10.1161/01.atv.0000145942.31404.20
发表时间: 2004-11-01
期刊: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
影响因子: 8.7
作者: [Gotoh, R, Suzuki, J, Isobe, M]
通讯作者: Isobe, M
Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury
小分子选择素拮抗剂阻断细胞粘附可减轻心肌缺血/再灌注损伤
DOI: --
发表时间: 2003
期刊: Eur J Pharmacol. 481
影响因子: --
作者: [Y.Onai, J.Suzuki, Y.Nishiwaki, R.Gotoh, K.Berens, R.Dixon, M.Yoshida, H.Ito, M.Isobe]
通讯作者: M.Isobe
25
    The role of residual dendritic cell in the early phase of atherosclerosis
    • 批准号:
      16K15439
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.08万
    • 财政年份:
      2016
    • 负责人:
      YOSHIDA Masayuki
    • 依托单位:
    Molecular mechanisms of vascular inflammation induced by uremic toxins
    • 批准号:
      24591111
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2012
    • 负责人:
      YOSHIDA Masayuki
    • 依托单位:
    Developing a model of product innovation at sporting events
    • 批准号:
      23700753
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.33万
    • 财政年份:
      2011
    • 负责人:
      YOSHIDA Masayuki
    • 依托单位:
    Real-time imaging of inflammatory reactions and their related metabolic factors in vivo
    • 批准号:
      18590805
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.39万
    • 财政年份:
      2006
    • 负责人:
      YOSHIDA Masayuki
    • 依托单位:
    海外基金